All reactions were carried out with magnetic stir and in dried glassware. Standard syringe techniques were applied for transfer of dry solvents. All solvents before used were dried and distilled under standard methods. All materials were from commercial suppliers and used without purification. We used DMSO-d 6 as the solvent of all products for the 1 H and 13 C NMR assays, which spectra were recorded on a Bruker AVANCEш 400 spectrometer. Chemical shifts (δ) were reported in ppm relative to Me 4 Si (internal standard) and coupling constants (J) were reported in Hz.
General Information
All reactions were carried out with magnetic stir and in dried glassware. Standard syringe techniques were applied for transfer of dry solvents. All solvents before used were dried and distilled under standard methods. All materials were from commercial suppliers and used without purification. We used as the solvent of all products for the 1 H and 13 C NMR assays, which spectra were recorded on a Bruker AVANCEш 400 spectrometer. Chemical shifts (δ) were reported in ppm relative to Me 4 Si (internal standard) and coupling constants (J) were reported in Hz.
Proton ( 1 H NMR) and carbon ( 13 C NMR) nuclear magnetic resonance spectra were recorded at 400 MHz and 101MHz, respectively. The chemical shifts are given in parts per million (ppm) on the delta (δ) scale. The following abbreviations were used to explain multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and br = broad. Thin layer chromatography (TLC) and column chromatography were used Qingdao Haiyang Silica gel F-254 plates and Qingdao Haiyang Silica gel 60 (300-400 mesh). HPLC analysis was performed on an UltiMate 3000 HPLC system (Dionex, USA). High-resolution mass spectra (HRMS) were obtained on an Agilent mass spectrometer using ESI-TOF (electrospray ionization-time of flight).
Experimental Section

Synthesis of 9a -9b
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 9a
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To a solution of 6-bromo-1H-indazole 8a (8.0 g, 40 mmol), bis(pinacolato)-diboron (15.2 g, 60 mmol) and KOAc (7.84 g, 80 mmol) in 1,4-dioxane (100 mL), Pd(dppf)Cl 2 (1.46 g, 2 mmol) was added and the mixture was degassed for 5 min. The mixture was heated to 90°C for 8 h and cooled to r.t. The mixture was diluted with ethyl acetate and filtered through celite. The filtrate was washed successively with water and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by chromatography eluting with Pet:EtOAc=2 
Synthesis of 11a -11d
4-(1H-indazol-6-yl)pyrimidin-2-amine 11a
To a solution of 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 9a (3.66 g, 15 mmol), 4-chloropyrimidin-2-amine 10a (1.62 g, 12.5 mmol) and KOAc (2.34 g, 30 mmol) in 1,4-dioxane (100 mL), Pd(dppf)Cl 2 (0.45 g, 0.62 mmol) was added and the mixture was degassed for 5 min. The mixture was heated to 100°C for 3 h and cooled to r.t. The mixture was diluted with ethyl acetate and filtered through celite. 4-(5-methyl-1H-indazol-6-yl)pyrimidin-2-amine 11b
The title compound 11b was prepared from 9b and 10a following synthesis of 11a. 
4-(1H-indazol-6-yl)-N-methylpyrimidin-2-amine 11c
The title compound 11c was prepared from 9a and 4-chloro-N-methylpyrimidin-2-amine 10b following synthesis of 11a. 
Synthesis of 12a -12d
4-(3-iodo-1H-indazol-6-yl)pyrimidin-2-amine 12a 4-(1H-indazol-6-yl)pyrimidin-2-amine 11a (1.7 g, 8.0 mmol) and K 2 CO 3 (2.24 g, 16 mmol) were combined in DMF (15 mL), and I 2 (4. 0 g, 16 mmol) dissolved in DMF (2 mL) was added dropwise to the mixture, then stirred 10 h at 65°C. The reaction was then poured into a solution of sodium dithionite (3.0 g) and K 2 CO 3 (1. 
N-(4-(3-iodo-1H-indazol-6-yl)pyrimidin-2-yl)acetamide 12d
The title compound 12d was prepared from 11d following synthesis of 12a. Light yellow solid; yield 80.1%. 
Synthesis of 14a-14y, 15a-15d.
To a solution of 4-(3-iodo-1H-indazol-6-yl)pyrimidin-2-amine 12a (120 mg, 0.36 mmol), trans-arylvinylboronates or trans-hetarylvinylboronates 13a-13y (0.43 mmol) and cesium carbonate (234 mg, 0.72 mmol) in 1,4-dioxane:H 2 O=4:1 (15 mL), Pd(dppf)Cl 2 (29 mg, 0.04 mmol) was added and the mixture was degassed for 5 min. The mixture was heated to 100°C for 8 h and cooled to r.t. The mixture was diluted with ethyl acetate and filtered through celite. The filtrate was washed successively with water and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by chromatography eluting with DCM:CH 3 OH=10:1 to afford the title compounds 14a-14y. 159.53 , 142.84 , 142.04 , 137.55 , 135.66 , 130.15 , 129.19 , 128.20 , 126.95 , 122.32 , 121.40 , 120.79 , 120 23 , 159.57 , 142.05 , 136.72 , 135.55 , 131.98 , 130.72 , 128.20 , 126.83 , 121.53 , 120.72 , 119.86 , 118.02 , 117.90 , 110.78 , 109.22 , 106.74 , 101.86 93 , 148.99 , 148.87 , 142.82 , 142.24 , 137.93 , 137.19 , 136.40 , 129.90 , 129.77 , 126.79 , 121.90 , 121.16 , 120.55 , 120.31 , 110.91 , 108.43 , 105.93 , 66.69 , 62.67 , 53.66 25 , 164.11 , 159.60 , 142.85，142.04 , 142.03 , 137.48 , 135.65 , 130.14 , 129.10 , 127.74 , 125.65 , 122.25 , 121.49 , 120.88 , 120.06 , 109.27 , 106.73 , 66.59 , 53.62 , 40. 31 ,164.01 , 159.14 , 148.41 , 142.54 , 142.01 , 135.62 , 133.61 , 126.45 , 123.06 , 122.40 , 121.42 , 120.24 , 109.44 , 106.78 27, 164.27, 159.57 , 158.89 , 147.59 , 143.20 , 142.00 , 135.57 , 134.71 , 127.14 , 123.34 , 122.19, 121.41 , 119.81 , 117.93 , 109.20 , 107.51 , 106.71 , 66.41 , 45.54 26 , 164.17 , 159.57 , 158.99 , 147.68 , 143.15 , 142.10 , 135.55 , 134.57 , 127.28 , 122.62 , 122.16 , 121.42 , 119.79 , 117.39 , 109.31 , 107.37 , 106.71 , 46.11 , 45.78 164.09 , 159.60 , 158.16 , 153.09 , 151.47 , 145.10 , 137.73 , 135.65 , 130.58 , 130.24 , 124.00 , 121.47 , 119.99 , 119.17 , 109.31 , 109.14 , 106.71 , 54.81 , 49.02 26 , 164.14 , 159.57 , 158.50 ,154.42 , 147.61 , 143.20 , 141.99 , 135.57,134.78 , 127.13 , 123.17, 122.19 , 121.42 , 119.81 , 117.89 , 109.20 , 107.72 , 106.70 , 79.51 , 44.85 , 28.56 154.56 , 135.69 , 134.37 , 132.73 , 128.56 , 123.00 , 122.39 , 121.37 , 120.16 , 116.85 , 113.19 (d, J = 24. 26 , 164.07 , 159.61 , 152.95, 146.10, 142.10, 138.48, 135.68, 134.31, 128.33, 127.62 , 125.23 , 121.45, 120.13 , 106.72 , 60.72, 45.42 27 , 164.11 , 159.59 , 142.92 , 137.86 , 135.62 , 130.57 , 130.03 , 128.66 , 124.12 , 121.39 , 120.00 , 109.28 , 106.71 , 61.60, 45.52 , 19.27 ; 164.07 , 159.61 , 158.41 , 152.60 , 142.78 , 139.52 , 135.69 , 131.96 , 129.89 , 122.27 , 121.45 , 120.06 , 119.26 , 109.37 , 106.73 , 102.77 , 63.26, 56.16 , 44.19 164.04 , 161.33 , 159.61 , 158.86 , 149.15 , 142.62 , 135.72 , 131.88 , 127.66 , 125.38 , 123.52 , 122.35 , 121.68 , 121.01 , 120.28 , 116.14 (d, J = 22.0 Hz), 106.70 , 62.92 , 45.40 27 , 164.05 , 159.60 , 142.58 , 142.06 , 138.26 , 135.68 , 135.22 , 134.23 , 131.47 , 128.38 , 127.60 , 125.19 , 122.36 , 121.93 , 121.45 , 120.11 , 109.29 , 106.71 , 58.92 , 46.16 27 , 164.10 , 159.60 , 135.68 , 135.63 , 134.99 , 131.39 , 127.42 , 127.28 , 125.29 , 122.32 , 121.17 , 120.13 , 106.68 , 63.48 , 45.34 , 20. 24 , 164.13 , 159.59 , 156.98 , 135.61 , 126.61 , 124.69 , 122.31 , 121.66 , 120.99 , 120.06 , 112.16 , 106.72 , 63.62 , 56.07 , 45.27 423.1910, found: 423.1924 .
(E)-4-(3-(4-((dimethylamino)methyl)styryl)-1H-indazol-6-yl)pyrimidin-2-amine 14i
(E)-N-(4-(3-(4-((dimethylamino)methyl)styryl)-1H-indazol-6-yl)pyrimidin-2-yl)acetamide 15a
The title compound 15a-15b was prepared from 12d following synthesis of 14a-14y. 71 , 164.41 , 164.26 , 164.09 , 159.81 , 159.59 , 158.40 , 136.59 , 134.53 , 131.98 , 130.11 , 130.02 , 129.88 , 129.12 , 126.87 , 121.73 , 120.11 , 112.61 , 60.38 , 45.00 , 25.38 
